Methamphetamine administration produces immunomodulation in mice

Journal of Toxicology and Environmental Health - Part A

Volumn 68, Issue 23-24, 2005, Pages 2133-2145

  In, Sang Whan ^a   Son, Eun Wha ^b   Rhee, Dong Kwon ^a   Pyo, Suhkneung ^a  

^a Sungkyunkwan University   (South Korea)

^b Samcheok National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD4 ANTIGEN; CD8 ANTIGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 2; METHAMPHETAMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE ACTIVATION; BODY WEIGHT; CELL COUNT; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMORAL IMMUNITY; IMMUNE SYSTEM; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOMODULATION; IMMUNOSTIMULATION; IMMUNOTOXICITY; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; SHEEP ERYTHROCYTE; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; VIRUS CULTURE;

ANIMALS; ANTIBODY-PRODUCING CELLS; BONE MARROW CELLS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; COLONY-FORMING UNITS ASSAY; ERYTHROCYTES; GRANULOCYTES; IMMUNOGLOBULIN G; INTERLEUKIN-2; KILLER CELLS, NATURAL; MACROPHAGES; MALE; METHAMPHETAMINE; MICE; MICE, INBRED STRAINS; SHEEP; SPLEEN; T-LYMPHOCYTE SUBSETS; THYMUS GLAND;

ANIMALIA; OVIS ARIES;

EID: 28744448697     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/15287390500177156     Document Type: Article

References (25)

1. Briensven, F. V., Supawitkul, S., Elmarx, P. H., Limpakarnjanarat, K., Young, N. L., Manopaiboon, C., Mock, P. A., Korattana, S., and Mastro, T. D. 2001. Rapid assessment of sexual behavior, drug use, human immunodeficiency virus, and sexually transmitted diseases in northern Thai youth using audio-computer-assisted self-interviewing and noninvasive specimen collection. Pediatrics. 108:1-7.
2. Carter, K. C., Finnon, Y. S., Daeid, N. N., Robson, D. C., and Waddell, R. 2002. The effect of nitrostyrene on cell proliferation and macrophage immune responses. Immunopharmacol. Immunotoxicol. 24:187-197.
3. Connor, T. J., McNamara, M. G., Kelly, J. P., and Leonard, B. E. 1999. 3,4-Methylenedioxymethamphetamine (MDMA; Ecstasy) administration produces dose-dependent neurochemical, endocrine and immune changes in the rat. Hum. Psychopharmacol. 14:95-104.
4. Connor, T. J., Kelly, J. P., McGee, M., and Leonard, B. E. 2000. Methylenedioxymethamphetamine suppresses IL-1 beta and TNF-alpha secretion following an in vivo lipopolysaccharide challenge. Life Sci. 67:1601-1612.
5. Connor, T. J., Connelly, D. B., and Kelly, J. P. 2001. Methylenedioxymethamphetamine suppresses antigen specific IgG2a and IFN-gamma production. Immunol. Lett. 78:67-73.
6. Dhabhar, F. S., Miller, A. H., McEwen, B. S., and Spencer, R. L. 1995. Effects of stress on immune cell distribution. Dynamics and hormonal mechanisms. J. Immunol. 154:5511-5527.
7. House, R. V., Thomas, P. T., and Bhargava, H. N. 1994. Comparison of immune functional parameters following in vitro exposure to natural and synthetic amphetamines. Immunopharmacol. Immunotoxicol. 16:1-21.
8. House, R. V., Thomas, P. T., and Bhargava, H. N. 1995. Selective modulation of immune function resulting from in vitro exposure to methylenedioxymethamphetamine (Ecstasy). Toxicology. 96:59-69.
9. In, S. W., Son, E. H., Rhee, D. K., and Pyo, S. 2004. Modulation of murine macrophage function by methamphetamine. J. Toxicol. Environ. Health A. 67:1923-1937.
10. Institoris, L., Siroki, O., and Desi, I. 1995. Immunotoxicity study of repeated small doses of dimethoate and methylparathion administered to rats over three generations. Hum. Exp. Toxicol. 14:879-883.
11. Iwasa, M., Maeno, Y., Inoue, H., Koyama, H., and Matoba, R. 1996. Induction of apoptotic cell death in rat thymus and spleen after a bolus injection of methamphetamine. Int. J. Legal Med. 109:23-28.
12. Kim, S., Stair, E. L., Lish, J. W., Lochmiller, R. L., Rafferty, D. P., and Quails, C. W. 2001. Evaluation of myelotoxicity in cotton rats (Sigmodon hispidus) exposed to environmental contaminants. II. Myelotoxicity associated with petroleum industrial wastes. J. Toxicol. Environ. Health. A 62:97-105.
13. Kubera, M., Filip, M., Basta-Kaim, A., Nowak, E., Budziszewska, B., Tetich, M., Holan, V., Korzeniak, B., and Przegalinski, E. 2002. The effect of amphetamine sensitization on mouse immunoreactivity. J. Physiol. Pharmacol. 53:233-242.
14. Leonard, W. 1999. Type I cytokines and interferon and their receptors. In Fundamental immunology, ed. W. E. Paul, pp. 745-747. Philadelphia: Raven.
15. MacKenzie, R. G., and Heischober, B. 1997. Methamphetamine. Pediatr. Rev. 18:305-309.
16. Moretta, L., Ciccone, E., Moretta, A., Hoglund, P., Ohlen, C., and Karre, K. 1992. Allorecognition by NK cells: Nonself or no self? Immunol. Today. 13:300-306.
17. Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65:55-63.
18. Mossner, R., and Lesch, K. P. 1998. Role of serotonin in the immune system and in neuroimmune interactions. Brain Behav. Immunol. 12:249-271.
19. Rothman, R. B., Baumann, M. H., Dersch, C. M., Romero, D. V., Rice, K. C., Carroll, F. I., and Partilla, J. S. 2001. Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse. 39:32-41.
20. Ruth, J. A., Granewald, G. L., and Rutledge, C. O. 1978. Conformationally defined adrenergic agents. III. The importance of compartmentation in the release of norepinephrine from rat atria by endo- and exo-2- methylaminobenzobicyclo-[2.2.2] octene, conformationally defined analogs of methamphetamine. J. Pharmacol. Exp. Ther. 204:615-624.
21. Wagner, G. C., Ricaurte, G. A., Seiden, L. S., Schuster, C. R., Miller, R. J., and Westley, J. 1980. Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine. Brain Res. 181:151-160.
22. Wermuth, L. 2000. Methamphetamine use: Hazards and social influences. J. Drug Educ. 30:423-433.
23. Yu, Q., Zhang, D., Walston, M., Zhang, J., Liu, Y., and Watson, R. R. 2002. Chronic methamphetamine exposure alters immune function in normal and retrovirus-infected mice. Int. Immunopharmacol. 2:951-962.
24. Yu, Q., Larson, D. F., and Watson, R. R. 2003. Heart disease, methamphatamine and AIDS. Life Sci. 73:129-140.
25. Zule, W.A., and Desmond, D.P. 1999. An ethnographic comparison of HIV risk behaviors among heroin and methamphetamine injectors. Am. J. Drug Alcohol Abuse. 25:1-23.